Iprensa

Ibuprofen, the active ingredient in Iprensa, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It treats mild to moderate pain, fever, and inflammatory conditions such as arthritis in adults.

GNH USA supplies Iprensa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts on inflammatory pathways to relieve pain and reduce fever. - Mild to moderate pain: provides analgesic relief for headaches, dental pain, musculoskeletal discomfort. - Fever: lowers elevated body temperature by acting on the hypothalamic heat‑regulation center. - Arthritis (inflammatory joint conditions): decreases joint inflammation and associated pain, improving mobility.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache or dizziness. - Mild skin rash or itching. - Elevated blood pressure in some patients. - Fluid retention or mild edema.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. - Acute renal failure or worsening of chronic kidney disease. - Hepatotoxicity presenting as jaundice or abnormal liver enzymes. - Cardiovascular events including myocardial infarction or stroke, especially with high‑dose or prolonged use.

Before using ibuprofen, consider the following precautions: - Assess renal function: avoid or adjust use in patients with significant kidney impairment. - Evaluate gastrointestinal risk: contraindicated in active ulcer disease or recent GI bleeding. - Consider cardiovascular risk: use cautiously in patients with heart disease or hypertension. - Avoid in third‑trimester pregnancy: consult a healthcare professional for alternative therapy. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Ibuprofen may interact with several medicines. Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function, especially in dehydrated patients. - Diuretics: potential for reduced kidney perfusion and electrolyte imbalance. - Lithium: ibuprofen can raise serum lithium concentrations, requiring monitoring.